{"entity":{"type":"insider","cik":"0001461959","url":"/insider/0001461959","json_url":"/insider/0001461959.json","name":"Rosenstadt William S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":37,"n_filings":4,"first":"2017-03-30","last":"2025-12-08","span_basis":"filed_date"},"name_variants":[{"name":"Rosenstadt William S","source":"filing","n_filings":4,"first_seen":"2017-03-30","last_seen":"2025-12-08"}],"transactions":[{"id":4490419,"accession":"0001185185-25-001967","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001185185-25-001967","line_url":"/filing/0001185185-25-001967#line-1","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Blueport Acquisition Ltd","issuer_ticker":"BPAC","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (CEO and Chairman), Ten percent owner","officer_title":"CEO and Chairman","security_title":"Class A Ordinary Share, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":197250.0,"shares_display":"197,250","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"shares_owned_after":1634750.0,"shares_owned_after_display":"1,634,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-11-13","filed_date":"2025-12-08","scope":"insider"},{"id":4429511,"accession":"0001461959-17-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001461959-17-000004","line_url":"/filing/0001461959-17-000004#line-2","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":7.6,"price_display":"7.60","price_state":"stated","total_value":38000.0,"total_display":"38,000.00","shares_owned_after":975549.0,"shares_owned_after_display":"975,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-30","filed_date":"2017-04-14","scope":"insider"},{"id":4429508,"accession":"0001461959-17-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001461959-17-000004","line_url":"/filing/0001461959-17-000004#line-1","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":5.29,"price_display":"5.29","price_state":"stated","total_value":23276.0,"total_display":"23,276.00","shares_owned_after":980549.0,"shares_owned_after_display":"980,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-29","filed_date":"2017-04-14","scope":"insider"},{"id":9289190,"accession":"0001461959-17-000003","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-17","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":5.09,"price_display":"5.09","price_state":"stated","total_value":25450.0,"total_display":"25,450.00","shares_owned_after":984949.0,"shares_owned_after_display":"984,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-28","filed_date":"2017-03-30","scope":"insider"},{"id":4429503,"accession":"0001461959-17-000002","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-17","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":5.09,"price_display":"5.09","price_state":"stated","total_value":25450.0,"total_display":"25,450.00","shares_owned_after":36949.0,"shares_owned_after_display":"36,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-28","filed_date":"2017-03-30","scope":"insider"},{"id":9289204,"accession":"0001461959-17-000003","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-16","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":23600.0,"total_display":"23,600.00","shares_owned_after":989949.0,"shares_owned_after_display":"989,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-27","filed_date":"2017-03-30","scope":"insider"},{"id":4429499,"accession":"0001461959-17-000002","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-16","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":4.72,"price_display":"4.72","price_state":"stated","total_value":23600.0,"total_display":"23,600.00","shares_owned_after":41949.0,"shares_owned_after_display":"41,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-27","filed_date":"2017-03-30","scope":"insider"},{"id":9289203,"accession":"0001461959-17-000003","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-15","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":4.56,"price_display":"4.56","price_state":"stated","total_value":16872.0,"total_display":"16,872.00","shares_owned_after":994949.0,"shares_owned_after_display":"994,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-24","filed_date":"2017-03-30","scope":"insider"},{"id":4429495,"accession":"0001461959-17-000002","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-15","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":4.56,"price_display":"4.56","price_state":"stated","total_value":16872.0,"total_display":"16,872.00","shares_owned_after":46949.0,"shares_owned_after_display":"46,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-24","filed_date":"2017-03-30","scope":"insider"},{"id":9289202,"accession":"0001461959-17-000003","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-14","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":23550.0,"total_display":"23,550.00","shares_owned_after":998649.0,"shares_owned_after_display":"998,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-23","filed_date":"2017-03-30","scope":"insider"},{"id":4429491,"accession":"0001461959-17-000002","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-14","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":23550.0,"total_display":"23,550.00","shares_owned_after":50649.0,"shares_owned_after_display":"50,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-23","filed_date":"2017-03-30","scope":"insider"},{"id":9289201,"accession":"0001461959-17-000003","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-13","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.87,"price_display":"3.87","price_state":"stated","total_value":19350.0,"total_display":"19,350.00","shares_owned_after":1003649.0,"shares_owned_after_display":"1,003,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-22","filed_date":"2017-03-30","scope":"insider"},{"id":4429486,"accession":"0001461959-17-000002","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-13","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.87,"price_display":"3.87","price_state":"stated","total_value":19350.0,"total_display":"19,350.00","shares_owned_after":55649.0,"shares_owned_after_display":"55,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-22","filed_date":"2017-03-30","scope":"insider"},{"id":9289200,"accession":"0001461959-17-000003","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-12","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":7480.0,"total_display":"7,480.00","shares_owned_after":1008649.0,"shares_owned_after_display":"1,008,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-21","filed_date":"2017-03-30","scope":"insider"},{"id":4429485,"accession":"0001461959-17-000002","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-12","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":7480.0,"total_display":"7,480.00","shares_owned_after":60649.0,"shares_owned_after_display":"60,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-21","filed_date":"2017-03-30","scope":"insider"},{"id":9289198,"accession":"0001461959-17-000003","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-11","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":6441.0,"total_display":"6,441.00","shares_owned_after":1010849.0,"shares_owned_after_display":"1,010,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-03-30","scope":"insider"},{"id":4429481,"accession":"0001461959-17-000002","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-11","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":3.39,"price_display":"3.39","price_state":"stated","total_value":6441.0,"total_display":"6,441.00","shares_owned_after":62849.0,"shares_owned_after_display":"62,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-03-30","scope":"insider"},{"id":9289197,"accession":"0001461959-17-000003","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-10","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.9,"price_display":"2.90","price_state":"stated","total_value":290.0,"total_display":"290.00","shares_owned_after":1012749.0,"shares_owned_after_display":"1,012,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-30","scope":"insider"},{"id":4429477,"accession":"0001461959-17-000002","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-10","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":2.9,"price_display":"2.90","price_state":"stated","total_value":290.0,"total_display":"290.00","shares_owned_after":64749.0,"shares_owned_after_display":"64,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-16","filed_date":"2017-03-30","scope":"insider"},{"id":9289196,"accession":"0001461959-17-000003","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-9","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":3900.0,"total_display":"3,900.00","shares_owned_after":1012849.0,"shares_owned_after_display":"1,012,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-30","scope":"insider"},{"id":4429473,"accession":"0001461959-17-000002","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-9","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":3900.0,"total_display":"3,900.00","shares_owned_after":64849.0,"shares_owned_after_display":"64,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-15","filed_date":"2017-03-30","scope":"insider"},{"id":9289195,"accession":"0001461959-17-000003","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-8","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":3.56,"price_display":"3.56","price_state":"stated","total_value":13528.0,"total_display":"13,528.00","shares_owned_after":1014049.0,"shares_owned_after_display":"1,014,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-09","filed_date":"2017-03-30","scope":"insider"},{"id":4429468,"accession":"0001461959-17-000002","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-8","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":3.56,"price_display":"3.56","price_state":"stated","total_value":13528.0,"total_display":"13,528.00","shares_owned_after":66049.0,"shares_owned_after_display":"66,049","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-09","filed_date":"2017-03-30","scope":"insider"},{"id":9289205,"accession":"0001461959-17-000003","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-7","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":3.73,"price_display":"3.73","price_state":"stated","total_value":3357.0,"total_display":"3,357.00","shares_owned_after":1017849.0,"shares_owned_after_display":"1,017,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-30","scope":"insider"},{"id":4429458,"accession":"0001461959-17-000002","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-7","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":3.73,"price_display":"3.73","price_state":"stated","total_value":3357.0,"total_display":"3,357.00","shares_owned_after":69849.0,"shares_owned_after_display":"69,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-30","scope":"insider"},{"id":9289206,"accession":"0001461959-17-000003","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-6","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.37,"price_display":"3.37","price_state":"stated","total_value":16850.0,"total_display":"16,850.00","shares_owned_after":1018749.0,"shares_owned_after_display":"1,018,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-22","filed_date":"2017-03-30","scope":"insider"},{"id":4429450,"accession":"0001461959-17-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-6","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.37,"price_display":"3.37","price_state":"stated","total_value":16850.0,"total_display":"16,850.00","shares_owned_after":70749.0,"shares_owned_after_display":"70,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-22","filed_date":"2017-03-30","scope":"insider"},{"id":9289191,"accession":"0001461959-17-000003","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-5","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":3.86,"price_display":"3.86","price_state":"stated","total_value":6948.0,"total_display":"6,948.00","shares_owned_after":1023749.0,"shares_owned_after_display":"1,023,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-17","filed_date":"2017-03-30","scope":"insider"},{"id":4429446,"accession":"0001461959-17-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-5","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":3.86,"price_display":"3.86","price_state":"stated","total_value":6948.0,"total_display":"6,948.00","shares_owned_after":75749.0,"shares_owned_after_display":"75,749","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-17","filed_date":"2017-03-30","scope":"insider"},{"id":9289192,"accession":"0001461959-17-000003","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-4","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","shares_owned_after":1025549.0,"shares_owned_after_display":"1,025,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-03-30","scope":"insider"},{"id":4429444,"accession":"0001461959-17-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-4","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","shares_owned_after":77549.0,"shares_owned_after_display":"77,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-16","filed_date":"2017-03-30","scope":"insider"},{"id":9289193,"accession":"0001461959-17-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-3","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4651.0,"shares_display":"4,651","price_per_share":3.27,"price_display":"3.27","price_state":"stated","total_value":15208.77,"total_display":"15,208.77","shares_owned_after":1026549.0,"shares_owned_after_display":"1,026,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-03-30","scope":"insider"},{"id":4429438,"accession":"0001461959-17-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-3","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4651.0,"shares_display":"4,651","price_per_share":3.27,"price_display":"3.27","price_state":"stated","total_value":15208.77,"total_display":"15,208.77","shares_owned_after":78549.0,"shares_owned_after_display":"78,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-14","filed_date":"2017-03-30","scope":"insider"},{"id":9289194,"accession":"0001461959-17-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-2","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":4.38,"price_display":"4.38","price_state":"stated","total_value":21900.0,"total_display":"21,900.00","shares_owned_after":1031200.0,"shares_owned_after_display":"1,031,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-10","filed_date":"2017-03-30","scope":"insider"},{"id":4429434,"accession":"0001461959-17-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-2","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":4.38,"price_display":"4.38","price_state":"stated","total_value":21900.0,"total_display":"21,900.00","shares_owned_after":83200.0,"shares_owned_after_display":"83,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-10","filed_date":"2017-03-30","scope":"insider"},{"id":9289199,"accession":"0001461959-17-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001461959-17-000003","line_url":"/filing/0001461959-17-000003#line-1","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel), Ten percent owner","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":16720.0,"total_display":"16,720.00","shares_owned_after":1036200.0,"shares_owned_after_display":"1,036,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-03-30","scope":"insider"},{"id":4429430,"accession":"0001461959-17-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001461959-17-000002","line_url":"/filing/0001461959-17-000002#line-1","is_derivative":false,"issuer_cik":"0001461959","issuer_name":"Q BioMed Inc.","issuer_ticker":"QBIO","issuer_name_source":null,"issuer_url":"/issuer/0001461959","owner_cik":"0001461959","owner_name":"Rosenstadt William S","owner_url":"/insider/0001461959","role":"Director, Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":4.4,"price_display":"4.40","price_state":"stated","total_value":16720.0,"total_display":"16,720.00","shares_owned_after":88200.0,"shares_owned_after_display":"88,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-09","filed_date":"2017-03-30","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":37,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":36,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":37},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002064177","name":"Blueport Acquisition Ltd","url":"/issuer/0002064177","role":"Director, Officer (CEO and Chairman), Ten percent owner","n_filings":1,"first_seen":"2025-12-08","last_seen":"2025-12-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001596062","name":"Q BioMed Inc.","url":"/issuer/0001596062","role":"Director, Officer (General Counsel), Ten percent owner","n_filings":3,"first_seen":"2017-03-30","last_seen":"2017-04-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001461959","retrieved_at":"2026-08-21T10:59:53+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}